All In MedTech

Device Trial Radar · NCT07499258

Axonics R20 Post-Market Clinical Follow-up (PMCF) Study for the Indication of Fecal Incontinence

Post-Market Clinical Follow-up Study of the Rechargeable Axonics SNM System INS Model 5101 (R20) for the Indication of Fecal Incontinence (FI)

Last checked: Nov 19, 2026Latest source record: Nov 12, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Recruiting

Status

Recruiting

Enrollment

55

Planned (sponsor's estimate)

Start

Jul 2, 2026

Primary completion

Aug 2027

Study completion Jun 2028

Sponsor

Lead sponsor
Axonics, Inc.Not on our public-company list
Sponsor type
Industry
First posted
Mar 30, 2026

More device trials from this sponsor

Design

Study type
Observational
FDA-regulated device
Yes
Who can join
All sexes, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

Single-Arm, multi-center, prospective, open-label registry study for commercially available rechargeable implantable neurostimulator (INS model 5101); also referred to as R20.

Conditions

  • Fecal Incontinence

Interventions

  • Axonics SNM System INS Model 5101 (R20)Device

    Participants treated with the rechargeable Axonics SNM System Model 5101 also referred to as R20. Commercial devices used in this study are within their intended use as described in each geography's approved instructions for use.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Performance/effectiveness - Improvement in Quality of Life scoring (FI)Time frame: 3 months
  2. Performance/effectiveness - Improvement in patient satisfaction scoring (FI)Time frame: 3 months

Locations

6 sites in 2 countries. Site status is shown where the registry gives one.

  • Columbia University Medical Center

    New York, New York · Recruiting

  • The Christ Hospital

    Cincinnati, Ohio · Recruiting

  • Female Urology of Nashville Research Partnership

    Nashville, Tennessee · Recruiting

3 more study sites with a free account

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.